Hassan Fred
SEC insider (Form 3/4/5 filer). CIK 0001110744. Director at BridgeBio Pharma, Inc. (BBIO) and 3 other issuers. 12 reported Form 4/5 transactions since Sep 2024; latest on Jun 22, 2026. Located in PALO ALTO, CA.
Companies Hassan Fred has filed insider reports for
- BridgeBio Pharma, Inc. (BBIO): Director
- PRECIGEN, INC. (PGEN): Director
- Cocrystal Pharma, Inc. (COCP): Director
- EyePoint, Inc. (EYPT): Director
Hassan Fred
CIK: 0001110744
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jun 22, 2026BBIO
BridgeBio Pharma, Inc.
AwardDirect4K shares- - Mar 13, 2026PGEN
PRECIGEN, INC.
ExerciseDirect71.8K shares- - Mar 10, 2026PGEN
PRECIGEN, INC.
AwardDirect17.9K shares at avg. $3.51$63K - Jan 9, 2026COCP
Cocrystal Pharma, Inc.
AwardDirectStock Options (Right to Buy)
16.4K shares- - Jan 2, 2026EYPT
EyePoint, Inc.
AwardDirectStock Option (Right to Buy)
40K shares- - Oct 28, 2025COCP
Cocrystal Pharma, Inc.
AwardDirect359.7K shares at avg. $1.39$500K - Jun 20, 2025BBIO
BridgeBio Pharma, Inc.
AwardDirect6.6K shares- - Mar 14, 2025PGEN
PRECIGEN, INC.
ExerciseDirect87.4K shares- - Mar 13, 2025PGEN
PRECIGEN, INC.
AwardDirect36.2K shares at avg. $1.74$63K - Jan 3, 2025EYPT
EyePoint Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
40K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 22, 2026 |  BBIO BridgeBio Pharma, Inc. | Award | 3,990 | - | $0 | Direct |
| Mar 13, 2026 |  PGEN PRECIGEN, INC. | Exercise | 71,839 | - | $0 | Direct |
| Mar 10, 2026 | PGEN PRECIGEN, INC. | Award | 17,948 | $3.51 | $62,997 | Direct |
| Jan 9, 2026 |  COCP Cocrystal Pharma, Inc. | Award Stock Options (Right to Buy) | 16,410 | - | - | Direct |
| Jan 2, 2026 |  EYPT EyePoint, Inc. | Award Stock Option (Right to Buy) | 40,000 | - | - | Direct |
| Oct 28, 2025 | COCP Cocrystal Pharma, Inc. | Award | 359,713 | $1.39 | $500,001 | Direct |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | Award | 6,589 | - | - | Direct |
| Mar 14, 2025 | PGEN PRECIGEN, INC. | Exercise | 87,412 | - | - | Direct |
| Mar 13, 2025 | PGEN PRECIGEN, INC. | Award | 36,206 | $1.74 | $62,998 | Direct |
| Jan 3, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 40,000 | - | - | Direct |
1-10 of 12 transactions